高血压对风湿性关节炎患者骨矿物质密度的影响
Praveen Pratap Jadhav1, Vivek Gajanan Patwardhan2
1Omkar Rheumatology Clinic, Gaikwad Mala, Nashik, India.
Mediterranean journal of rheumatology
|January 29, 2024
概括
类风湿性关节炎 (RA) 患者的高血压 (HT) 可能会改善骨矿物质密度 (BMD) 与单独的RA相比,但仍然低于健康个体. 建议在RA患者的BMD解释时谨慎.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 类风湿性关节炎 (RA) 与骨矿物质密度 (BMD) 的降低有关.
- 慢性疾病如II型糖尿病和高血压 (HT) 可以影响RA患者的BMD.
- 在新诊断的RA患者中,同时存在的HT对BMD的影响需要进行研究.
研究的目的:
- 确定高血压 (HT) 是否影响新诊断为类风湿性关节炎 (RA) 的患者的骨矿物质密度 (BMD) 参数.
主要方法:
- 分析了接受 BMD 评估的 RA 患者的研究群体.
- 患者被分为有HT和没有HT的组,以及健康的对照组.
- 使用GE Lunar DPX机器测量骨矿物质密度 (BMD),记录脊柱,大腿和全大腿的平均T分数.
主要成果:
- 年龄反向相关,而身体质量指数 (BMI) 与所有组的BMDT分数直接相关.
- 患有HT的RA患者的BMD比仅患有RA的患者高,但BMD比健康对照患者低.
- 多重回归分析表明,单独的BMI无法解释RA患者HT中观察到的T-分数升高.
结论:
- 在类风湿性关节炎 (RA) 患者中,高血压 (HT) 的存在似乎可以抵消RA的骨损伤作用,正如骨密度计所示.
- 对于具有同时存在HT的RA患者的骨矿物质密度 (BMD) 报告,应仔细考虑这种并发症.
更多相关视频
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
1.1K
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
143
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
734
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
734
Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
